Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. [Phase 3]
Phase 3 study evaluating RWJ-333369 as add-on therapy for partial onset seizures in epilepsy, assessing efficacy and safety. The trial statu…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study of lamotrigine 25 mg tablets under fed conditions conducted by IPCA L…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition [Phase 1]
A Phase 1 bioequivalence study evaluating lamotrigine 25 mg tablets (two 25 mg tablets) under fasting conditions has completed.
-
FDA approval · 2012-06-07FDA Approved: ZONISAMIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for zonisamide from Exelan Pharmaceuticals, Inc. The document indicates an approval of a supplementa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-31FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals Inc., authorizing changes to the approved product.
-
FDA approval · 2012-05-30FDA Approved: ZONISAMIDE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for zonisamide submitted by Viona Pharmaceuticals Inc under an ANDA. The action updates the labe…
-
FDA approval · 2012-05-30FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for zonisamide submitted by BluePoint Laboratories under ANDA 077651.
-
FDA approval · 2012-05-30FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for zonisamide submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
A completed naturalistic observational study by UCB Pharma evaluating how care services are used during the diagnostic process for epilepsy.
-
FDA approval · 2012-05-29FDA Approved: LEVETIRACETAM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved a generic levetiracetam under an original ANDA from Torrent Pharmaceuticals Limited. The product is indicated for seizure disor…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam [Phase 1]
Phase 1 clinical study in healthy volunteers to evaluate the neurocognitive effects of Brivaracetam, an antiepileptic drug, sponsored by UCB…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.
Real-world study evaluating the efficacy and safety of levetiracetam for epilepsy in routine clinical practice across Czech and Slovak Repub…
-
CLINICAL_TRIALS withdrawal · 2012-05-28Clinical Trial Update: Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy [Phase 3]
The Phase 3 open-label trial evaluating long-term safety and efficacy of seletracetam for epilepsy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
A completed cross-sectional study evaluating patient acceptability of the oral solution form of levetiracetam in epilepsy.
-
FDA approval · 2012-05-21FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for lamotrigine filed by Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2012-05-20FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Gabapentin from Ascend Laboratories, LLC, under an ANDA, indicating approval related to this gen…
-
FDA approval · 2012-05-18FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, granting approval of a generic lamotrigine pro…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy
A completed clinical trial evaluating emotion/behavior problems, neuropsychological functioning, and parental adjustment in children with ep…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Bipolar Disorder in Epilepsy
Clinical trial investigating bipolar disorder in epilepsy has completed. The study was sponsored by Northwell Health.
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy [Phase 3]
Phase 3 trial comparing lamotrigine to levetiracetam as initial monotherapy for epilepsy has completed.
-
FDA approval · 2012-05-03FDA Approved: ZARONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Zarontin (ethosuximide) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2012-05-01FDA Approved: GABAPENTIN — Original Application (Acella Pharmaceuticals, LLC)
FDA approves Acella Pharmaceuticals' Gabapentin generic (ANDA 076403). The approval allows the generic product to be marketed for the same i…
-
FDA approval · 2012-04-26FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA granted supplemental approval for a generic levetiracetam product from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-04-26FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Levetiracetam by Dr. Reddy's Laboratories Limited under the ANDA, reflecting an approved additio…